GET IN TOUCH

Naracoota Ltd (Alcidion Group Limited) Lodge Prospectus to raise $2.00m

[vc_row][vc_column width=”1/1″][vc_column_text disable_pattern=”true” align=”left” margin_bottom=”0″]Dear Investor

On behalf of the board of directors of Naracoota Resources Limited (Company), I am pleased to present this Prospectus and to offer to you the opportunity to invest in the Company, to be renamed “Alcidion Group Limited”.

On 18 August 2015, the Company announced it had entered into a binding term sheet with Alcidion Corporation Pty Ltd (ACN 093 148 488) (Alcidion), Professor Malcolm Pradhan and Mr Raymond Blight pursuant to which the Company agreed to acquire the entire issued share capital of Alcidion (Alcidion Acquisition). On 17 November 2015, the Company entered into the Share Purchase Agreement, which subject to satisfaction of certain conditions precedent, will give effect to the Alcidion Acquisition.

Alcidion provides intelligent informatics software for high performance healthcare that empowers clinicians with decision support tools to ensure the highest quality of care for their patients. Alcidion is an established player in the new digital economy and enjoys an impressive track record of continuous innovation that has seen the evolution of the “Miya Platform” and product suite. The “Miya Platform” is currently operational in 11 Australian hospitals.

The Company will hold a general meeting on 21 December 2015 to seek Shareholder approval for a number of resolutions to give effect to the Alcidion Acquisition. Refer to Section 1.5 for further details.

The Company has issued this Prospectus for:

  1. a public offering of 64,516,129 Shares at an issue price of $0.031 each to raise approximately $2,000,000 (before costs). The funds raised will be used to, among other things, satisfy the working capital requirements for the Company’s expanded business, following completion of the Alcidion Acquisition; and
  2. the purpose of re-complying with Chapters 1 and 2 of the Listing Rules, following a change to the nature and scale of the Company’s activities from a gold and copper exploration company to a health informatics technology business, following completion of the Alcidion Acquisition.

The Prospectus also contains:

  1. an offer of 400,000,000 Shares, 133,333,333 Class A Contingent Share Rights and 133,333,333 Class B Contingent Share Rights to the Alcidion Vendors (or their nominees) in consideration for the acquisition of all the issued capital in Alcidion; and
  2. an offer of 11,827,957 Class A Contingent Share Rights and 15,053,763 Class B Contingent Share Rights to Beacon in consideration for the initial introduction and structuring of the Alcidion Acquisition.

Refer to Section 1 for further details of the Offers.

Before making your decision to invest, I recommend that you carefully read the Prospectus in its entirety and seek independent professional advice.

On behalf of the board of directors of the Company, I look forward to welcoming you as a Shareholder.

Yours faithfully and on behalf of my fellow board members,

 

 

Josh Russell Puckridge
Director
Naracoota Resources Limited

 

 

A copy of the Prospectus is available to be downloaded from the link below:[/vc_column_text][mk_image src=”https://www.alcidion.com/wp-content/uploads/2015/12/Alcidion-Prospectus-PDF-Thumbnail-2.png” image_width=”200″ image_height=”350″ crop=”false” lightbox=”false” frame_style=”simple” target=”_self” caption_location=”inside-image” align=”left” margin_bottom=”10″ link=”http://naracoota.com.au/investor-relations/download-prospectus-2″][mk_image image_width=”800″ image_height=”350″ crop=”true” lightbox=”false” frame_style=”simple” target=”_self” caption_location=”inside-image” align=”left” margin_bottom=”10″][/vc_column][/vc_row]